Compound Detail
CHEMBL603469
LESTAURTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
Basic Information
| ChEMBL ID | CHEMBL603469 |
| Name | LESTAURTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | UIARLYUEJFELEN-LROUJFHJSA-N |
926
Targets
1,462
Activities
2
Assay Types
3
PK Parameters
20
Publications
10
Known Names
10
Indications
6
Mechanisms
Molecular Properties
439.5
MW (Da)
3.47
ALogP
6
HBA
3
HBD
88.7
PSA (Ų)
0.37
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase receptor FLT3 inhibitor | INHIBITOR | Receptor-type tyrosine-protein kinase FLT3 | ✓ | ✓ |
| Tyrosine-protein kinase JAK2 inhibitor | INHIBITOR | Tyrosine-protein kinase JAK2 | ✓ | ✓ |
| Nerve growth factor receptor Trk-A inhibitor | INHIBITOR | High affinity nerve growth factor receptor | ✓ | ✓ |
| Neurotrophic tyrosine kinase receptor type 2 inhibitor | INHIBITOR | BDNF/NT-3 growth factors receptor | ✓ | ✓ |
| NT-3 growth factor receptor inhibitor | INHIBITOR | NT-3 growth factor receptor | ✓ | ✓ |
| Tyrosine-protein kinase receptor RET inhibitor | INHIBITOR | Proto-oncogene tyrosine-protein kinase receptor Ret | ✓ | ✓ |
Indications
Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia Leukemia, Myeloid, Acute Multiple Myeloma Polycythemia Vera Prostatic Neoplasms, Castration-Resistant Psoriasis Thrombocythemia, Essential Neuroblastoma Primary Myelofibrosis
Activity Summary
Kd 843 meas. best 9.41
IC50 619 meas. best 9.48
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 0.88 | uM.hr | Mus musculus |
| Cmax | 140.0 | nM | Mus musculus |
| Tmax | 0.92 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 9 |
| 19654408 | 10.1182/blood-2009-05-222034 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 9 |
| 19654408 | 10.1182/blood-2009-05-222034 | Tyrosine-protein kinase ABL1 | 9 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 19654408 | 10.1182/blood-2009-05-222034 | Receptor-type tyrosine-protein kinase FLT3 | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 38843875 | 10.1021/acs.jmedchem.4c00197 | Tyrosine-protein kinase JAK2 | 7 |
| 19654408 | 10.1182/blood-2009-05-222034 | Mast/stem cell growth factor receptor Kit | 6 |
| 19654408 | 10.1182/blood-2009-05-222034 | Unchecked | 6 |
| 20156689 | 10.1016/j.bmc.2010.01.056 | Macrophage colony-stimulating factor 1 receptor | 6 |
| 19654408 | 10.1182/blood-2009-05-222034 | Epidermal growth factor receptor | 6 |
| 38843875 | 10.1021/acs.jmedchem.4c00197 | Unchecked | 4 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 19654408 | 10.1182/blood-2009-05-222034 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 19654408 | 10.1182/blood-2009-05-222034 | Mus musculus | 3 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 3 |
| 19654408 | 10.1182/blood-2009-05-222034 | Hepatocyte growth factor receptor | 3 |
Data from ChEMBL 36 via Core Engine